Prospective Association of Daily Steps with Cardiovascular Disease: A Harmonized Meta-Analysis

Authors

Amanda E. Paluch, University of Massachusetts Amherst
Shivangi Bajpai, University of Massachusetts Amherst
Marcel Ballin, Umeå Universitet
David R. Bassett, The University of Tennessee, Knoxville
Thomas W. Buford, UAB Department of Medicine
Mercedes R. Carnethon, Northwestern University Feinberg School of Medicine
Ariel Chernofsky, Boston University
Erin E. Dooley, The University of Alabama at Birmingham
Ulf Ekelund, Norges Idrettshøgskole
Kelly R. Evenson, UNC Gillings School of Global Public Health
Deborah A. Galuska, National Center for Chronic Disease Prevention and Health Promotion
Barbara J. Jefferis, UCL Medical School
Lingsong Kong, University of Massachusetts Amherst
William E. Kraus, Duke University School of Medicine
Martin G. Larson, Boston University
I. Min Lee, Harvard Medical School
Charles E. Matthews, National Cancer Institute (NCI)
Robert L. Newton, Pennington Biomedical Research Center
Anna Nordström, Umeå Universitet
Peter Nordström, Umeå Universitet
Priya Palta, Columbia University
Alpa V. Patel, American Cancer Society
Kelley Pettee Gabriel, The University of Alabama at Birmingham
Carl F. Pieper, Duke University School of Medicine
Lisa Pompeii, Baylor College of Medicine
Erika Rees-Punia, American Cancer Society
Nicole L. Spartano, Boston University Chobanian & Avedisian School of Medicine
Ramachandran S. Vasan, Boston University Chobanian & Avedisian School of Medicine
Peter H. Whincup, St George’s, University of London
Shengping Yang, Pennington Biomedical Research Center
Janet E. Fulton, National Center for Chronic Disease Prevention and Health Promotion

Document Type

Article

Publication Date

1-10-2023

Abstract

Background: Taking fewer than the widely promoted "10 000 steps per day" has recently been associated with lower risk of all-cause mortality. The relationship of steps and cardiovascular disease (CVD) risk remains poorly described. A meta-analysis examining the dose-response relationship between steps per day and CVD can help inform clinical and public health guidelines. Methods: Eight prospective studies (20 152 adults [ie, ≥18 years of age]) were included with device-measured steps and participants followed for CVD events. Studies quantified steps per day and CVD events were defined as fatal and nonfatal coronary heart disease, stroke, and heart failure. Cox proportional hazards regression analyses were completed using study-specific quartiles and hazard ratios (HR) and 95% CI were meta-analyzed with inverse-variance-weighted random effects models. Results: The mean age of participants was 63.2±12.4 years and 52% were women. The mean follow-up was 6.2 years (123 209 person-years), with a total of 1523 CVD events (12.4 per 1000 participant-years) reported. There was a significant difference in the association of steps per day and CVD between older (ie, ≥60 years of age) and younger adults (ie, <60 years of age). For older adults, the HR for quartile 2 was 0.80 (95% CI, 0.69 to 0.93), 0.62 for quartile 3 (95% CI, 0.52 to 0.74), and 0.51 for quartile 4 (95% CI, 0.41 to 0.63) compared with the lowest quartile. For younger adults, the HR for quartile 2 was 0.79 (95% CI, 0.46 to 1.35), 0.90 for quartile 3 (95% CI, 0.64 to 1.25), and 0.95 for quartile 4 (95% CI, 0.61 to 1.48) compared with the lowest quartile. Restricted cubic splines demonstrated a nonlinear association whereby more steps were associated with decreased risk of CVD among older adults. Conclusions: For older adults, taking more daily steps was associated with a progressively decreased risk of CVD. Monitoring and promoting steps per day is a simple metric for clinician-patient communication and population health to reduce the risk of CVD.

This document is currently not available here.

Share

COinS